中国医药
中國醫藥
중국의약
CHINA MEDICINE
2010年
7期
588-590
,共3页
林梅%林婷%张菁%李一梓%张良琼%庞宝森%王左敏
林梅%林婷%張菁%李一梓%張良瓊%龐寶森%王左敏
림매%림정%장정%리일재%장량경%방보삼%왕좌민
牙周炎%肺疾病%慢性阻塞性%血清%白细胞介素-19
牙週炎%肺疾病%慢性阻塞性%血清%白細胞介素-19
아주염%폐질병%만성조새성%혈청%백세포개소-19
Periodontitis%Pulmonary disease,chronic obstructive%Serum%Interleukin-19
目的 通过比较慢性阻塞性肺疾病(COPD)患者、慢性中重度牙周炎患者和COPD合并中重度慢性牙周炎患者血清中白细胞介素19(IL-19)的含量,探讨中重度慢性牙周炎和COPD之间可能存在的关系.方法 选取临床确诊的COPD患者51例,中重度慢性牙周炎患者61例,COPD合并中重度慢性牙周炎患者97例,健康成人22名共计4组.收集各组受试者静脉血清样本,采用酶联免疫吸附法测定血清IL-19水平.结果 慢性中重度牙周炎患者血清IL-19含量(106.31±32.45)ng/L与非牙周炎患者血清IL-19(95.54±39.21)ng/L含量差异有统计学意义(P<0.05),COPD患者血清IL-19含量(107.41±38.43)ng/L与非COPD患者(94.48±33.23)ng/L差异也有统计学意义(P<0.05),但析因设计方差分析发现在慢性牙周炎与COPD之间的交互作用P>0.05,即不能认为两者之间存在交互影响.结论 血清中IL-19的表达可能与COPD及中重度慢性牙周炎发病机制有关.
目的 通過比較慢性阻塞性肺疾病(COPD)患者、慢性中重度牙週炎患者和COPD閤併中重度慢性牙週炎患者血清中白細胞介素19(IL-19)的含量,探討中重度慢性牙週炎和COPD之間可能存在的關繫.方法 選取臨床確診的COPD患者51例,中重度慢性牙週炎患者61例,COPD閤併中重度慢性牙週炎患者97例,健康成人22名共計4組.收集各組受試者靜脈血清樣本,採用酶聯免疫吸附法測定血清IL-19水平.結果 慢性中重度牙週炎患者血清IL-19含量(106.31±32.45)ng/L與非牙週炎患者血清IL-19(95.54±39.21)ng/L含量差異有統計學意義(P<0.05),COPD患者血清IL-19含量(107.41±38.43)ng/L與非COPD患者(94.48±33.23)ng/L差異也有統計學意義(P<0.05),但析因設計方差分析髮現在慢性牙週炎與COPD之間的交互作用P>0.05,即不能認為兩者之間存在交互影響.結論 血清中IL-19的錶達可能與COPD及中重度慢性牙週炎髮病機製有關.
목적 통과비교만성조새성폐질병(COPD)환자、만성중중도아주염환자화COPD합병중중도만성아주염환자혈청중백세포개소19(IL-19)적함량,탐토중중도만성아주염화COPD지간가능존재적관계.방법 선취림상학진적COPD환자51례,중중도만성아주염환자61례,COPD합병중중도만성아주염환자97례,건강성인22명공계4조.수집각조수시자정맥혈청양본,채용매련면역흡부법측정혈청IL-19수평.결과 만성중중도아주염환자혈청IL-19함량(106.31±32.45)ng/L여비아주염환자혈청IL-19(95.54±39.21)ng/L함량차이유통계학의의(P<0.05),COPD환자혈청IL-19함량(107.41±38.43)ng/L여비COPD환자(94.48±33.23)ng/L차이야유통계학의의(P<0.05),단석인설계방차분석발현재만성아주염여COPD지간적교호작용P>0.05,즉불능인위량자지간존재교호영향.결론 혈청중IL-19적표체가능여COPD급중중도만성아주염발병궤제유관.
Objective Periodontitis is an inflammatory disease which may be associated with chronic obstructive pulmonary disease (COPD). Interleukin-19 (IL-19) might be involved in the common inflammatory mechanisms. This study investigated the association of serum levels of IL-19 with periodontitis and COPD in a Chinese population. Methods Fifty-one patients with chronic obstructive pulmonary disease, sixty-one patients with periodontitis, ninety-seven patients with both COPD and periodontitis and twenty-two healthy people were included in the study. The blood serum IL-19 levels was detected by ABC-ELISA. Results The differences in IL-19 expression were significant both between periodontitis group and non-periodontitis group, COPD group and non-COPD group (P < 0.05). However, there was no interaction detected between the two diseases on IL-19 expression. Conclusion Serum IL-19 level increases in both periodontitis patients and COPD patientsand IL-19 might be associated with the pathogenesis of periodontitis and COPD.